Titan Pharmaceuticals
TTNP
#10533
Rank
NZ$10.36 M
Marketcap
NZ$7.80
Share price
-3.76%
Change (1 day)
15.20%
Change (1 year)

EPS for Titan Pharmaceuticals (TTNP)

EPS in 2025 (TTM): NZ-$7.22

According to Titan Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is NZ-$7.42. In 2023 the company made an earnings per share (EPS) of NZ-$12.53 an increase over its 2022 EPS that were of NZ-$25.68.

EPS history for Titan Pharmaceuticals from 1996 to 2025

Annual EPS

Year EPS Change
2025 (TTM)NZ-$7.22
2023NZ-$12.53-51.22%
2022NZ-$25.68-15.61%
2021NZ-$30.44-81.37%
2020NZ-$163.34-77.52%
2019NZ-$726.75-56.32%
2018NZ-$1,664-59.51%
2017NZ-$4,110-371.81%
2016NZ$1,512-144.35%
2015NZ-$3,409300%
2014NZ-$852.22-121.54%
2013NZ$3,957-151.38%
2012NZ-$7,700-11.54%
2011NZ-$8,705188.89%
2010NZ-$3,013-10%
2009NZ-$3,348
2007NZ-$13,727-2.38%
2006NZ-$14,062-39.13%
2005NZ-$23,101-16.87%
2004NZ-$27,789-22.43%
2003NZ-$35,8244.9%
2002NZ-$34,15061.9%
2001NZ-$21,092-13.7%
2000NZ-$24,44065.01%
1999NZ-$14,812-35.87%
1998NZ-$23,097-1824.71%
1997NZ$1,339-102.4%
1996NZ-$55,912

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
NZ$18.83-353.73%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
NZ$12.17-264.01%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Vanda Pharmaceuticals
VNDA
NZ-$2.40-67.65%๐Ÿ‡บ๐Ÿ‡ธ USA
Repligen
RGEN
NZ$1.47-119.82%๐Ÿ‡บ๐Ÿ‡ธ USA
MediciNova
MNOV
NZ-$0.42-94.31%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
NZ-$6.58-11.39%๐Ÿ‡บ๐Ÿ‡ธ USA